News
NEOG
12.37
+0.49%
0.06
Baron Health Care Fund Q1 2024 Shareholder Letter
Baron Health Care Fund advanced 8.92% in the quarter ended March 31, 2024. The Fund's performance was in line with the Russell 3000 Health Care Index and the S&P 500 Index. Investments in health care equipment, pharmaceuticals, and life sciences added the most value in the period.
Seeking Alpha · 2d ago
Validea Detailed Fundamental Analysis - NEOG
NASDAQ · 2d ago
Neogen (NEOG) Inks Genomics Deal to Aid in Food Tracing
NASDAQ · 2d ago
Weekly Report: what happened at NEOG last week (0415-0419)?
Weekly Report · 3d ago
Insiders Buying Rocket Companies And 2 Other Stocks
U.S. Stocks closed lower on Wednesday. There were a few notable insider trades. Rocket Companies, Inc. And Neogen Corporation made notable insider purchases. Steel Connect, Inc bought 42,309 shares at an average price of $9.22 to acquire $390,000.
Benzinga · 04/18 12:47
NEOGEN CORP - FORMED GENOMICS RELATIONSHIP WITH PERFORMANCE FOOD GROUP MAKING CO OFFICIAL GENOMICS PROVIDER FOR FOOD GROUP'S PATHPROVEN SERVICE
Reuters · 04/18 12:46
Neogen Price Target Cut to $17.00/Share From $19.00 by Piper Sandler
Dow Jones · 04/15 13:50
Neogen Is Maintained at Neutral by Piper Sandler
Dow Jones · 04/15 13:50
Piper Sandler Maintains Neutral on Neogen, Lowers Price Target to $17
Benzinga · 04/15 13:40
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Argenx Se (ARGX), Neogen (NEOG) and Supernus Pharmaceuticals (SUPN)
TipRanks · 04/15 11:10
Weekly Report: what happened at NEOG last week (0408-0412)?
Weekly Report · 04/15 09:27
U.S. RESEARCH ROUNDUP- Blackstone, Coupang, Wells Fargo
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Blackstone, Coupang, Wells Fargo & Co and Union Pacific raise their targets. 4D Molecular Therapeutics and Astera Labs are among the companies with new coverage on Monday.
Reuters · 04/15 06:58
NEOGEN CORP <NEOG.O>: PIPER SANDLER CUTS TARGET PRICE TO $17 FROM $19
Reuters · 04/15 03:56
Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust
Neogen's acquisition of 3M's food safety operations has hurt the company's financial performance and credibility with investors. The company's disappointing FQ3'24 results and ongoing operating inefficiencies have led to another cut in guidance for revenue and EBITDA. Neogen's shares should trade in the mid-teens, but rebuilding investor trust is key.
Seeking Alpha · 04/15 02:37
Insiders Buying SMART Global Holdings And 2 Other Stocks
U.S. Stocks closed mostly higher on Thursday. There were a few notable insider trades. Lennar Corporation and SMART Global Holdings, Inc. Made notable insider purchases. When insiders purchase shares, it indicates confidence in the company's prospects or that they view the stock as a bargain.
Benzinga · 04/12 11:17
Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Neogen Corporation (NASDAQ:NEOG) reported its quarterly results last week. The company reported a loss of US$0.01 per share on revenues of US $229m. The analysts have revised down their revenue and earnings per share estimates for the company. Neogen's shares are down 7.7% since the report, but the consensus price target has risen to US$19.00. We look at the analysts' most recent forecasts for Neogen following the results.
Simply Wall St · 04/12 11:05
Thursday 4/11 Insider Buying Report: NEOG, CRMT
NASDAQ · 04/11 14:54
Neogen (NEOG) Q3 Earnings Miss Estimates, Gross Margin Expands
NASDAQ · 04/10 12:06
Neogen Corporation Quarterly Report for the Period Ending February 29, 2024
Press release · 04/09 22:15
Here's What Key Metrics Tell Us About Neogen (NEOG) Q3 Earnings
NASDAQ · 04/09 21:30
More
Webull provides a variety of real-time NEOG stock news. You can receive the latest news about Neogen Corp through multiple platforms. This information may help you make smarter investment decisions.
About NEOG
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. Its Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.